PharmaBlock Sciences Nanjing Inc Class A (300725) — Capital Reinvestment Ratio
PharmaBlock Sciences Nanjing Inc Class A (300725) has a Capital Reinvestment Ratio of 0.05x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥83.36 Million) in capital expenditures (CN¥4.24 Million). Check PharmaBlock Sciences Nanjing Inc Class A tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
PharmaBlock Sciences Nanjing Inc Class A Capital Reinvestment Ratio (2013–2025)
This chart tracks PharmaBlock Sciences Nanjing Inc Class A's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see PharmaBlock Sciences Nanjing Inc Class A (300725) cash flow conversion.
Annual Capital Reinvestment Ratio for PharmaBlock Sciences Nanjing Inc Class A (2013–2025)
Year-by-year Capital Reinvestment Ratio for PharmaBlock Sciences Nanjing Inc Class A from 2013 to 2025. See cash generation quality of PharmaBlock Sciences Nanjing Inc Class A to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.21x | CN¥667.36 Million | CN¥140.13 Million | ▼ -46.2% |
| 2024 | 0.39x | CN¥302.82 Million | CN¥118.12 Million | ▼ -69.5% |
| 2023 | 1.28x | CN¥246.84 Million | CN¥315.77 Million | ▼ -43.5% |
| 2022 | 2.26x | CN¥246.61 Million | CN¥557.91 Million | ▲ +6.5% |
| 2021 | 2.12x | CN¥238.03 Million | CN¥505.76 Million | ▲ +667.3% |
| 2020 | 0.28x | CN¥271.51 Million | CN¥75.18 Million | ▼ -79.7% |
| 2019 | 1.37x | CN¥127.04 Million | CN¥173.52 Million | ▲ +351.6% |
| 2018 | 0.30x | CN¥160.16 Million | CN¥48.44 Million | ▼ -66.3% |
| 2017 | 0.90x | CN¥54.64 Million | CN¥49.06 Million | ▼ -46.6% |
| 2016 | 1.68x | CN¥22.76 Million | CN¥38.26 Million | ▲ +376.9% |
| 2015 | 0.35x | CN¥27.52 Million | CN¥9.70 Million | ▼ -55.7% |
| 2014 | 0.80x | CN¥11.91 Million | CN¥9.48 Million | ▲ +133.9% |
| 2013 | 0.34x | CN¥18.32 Million | CN¥6.23 Million | — |